Are you Dr. Haluska?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 52 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
750 Washington St
Nemc Box #836
Boston, MA 02111Phone+1 617-636-5000- Is this information wrong?
Summary
- Dr. Frank Haluska, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1991 - 1995
- Massachusetts General HospitalResidency, Internal Medicine, 1989 - 1991
- Perelman School of Medicine at the University of PennsylvaniaClass of 1989
Certifications & Licensure
- MA State Medical License 1991 - 2025
Clinical Trials
- S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Start of enrollment: 2000 Aug 01
- Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) Start of enrollment: 2003 May 01
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsPhase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers.Suzanne George, Margaret von Mehren, Jonathan A Fletcher, Jichao Sun, Sen Zhang, Justin R Pritchard, John Graeme Hodgson, David Kerstein, Victor M Rivera, Frank G Halu...> ;Clinical Cancer Research. 2022 Apr 1
- 400 citationsBrigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialDong Wan Kim, Marcello Tiseo, Myung-Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang-We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian Hochmair, ...> ;Journal of Clinical Oncology. 2017 May 5
- 31 citationsPonatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 studyArinobu Tojo, Taiichi Kyo, Kazuhito Yamamoto, Hirohisa Nakamae, Naoto Takahashi, Yukio Kobayashi, Tetsuzo Tauchi, Shinichiro Okamoto, Koichi Miyamura, Kiyohiko Hatake,...> ;International Journal of Hematology. 2017 Apr 25
- Join now to see all
Press Mentions
- Anchiano Appoints Steve DiPalma as Chief Financial OfficerMay 5th, 2020
- Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare ConferenceSeptember 20th, 2019
- Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceSeptember 3rd, 2019
- Join now to see all
Grant Support
- Genetics Of RAS, PTEN, BRAF And CDKN2A In MelanomaNational Cancer Institute2006
- Genetics Of RAS, PTEN, BRAF And CDKN2A In MelanomaNational Cancer Institute2005
- Peptide-Pulsed Dendritic Cell Therapy For MelanomaNational Cancer Institute1999–2000